Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Slit-skin smear in post kala-azar dermal leishmaniasis and leprosy: How a negative report for Leishman-Donovan bodies in Giemsa stain may indicate leprosy.

Chatterjee K, Yadav V, Ramesh V. JAAD international. 2023;
Download PDF
Publication

Mounting Evidence Suggests Leprosy Is Endemic in Florida.

Harris E. JAMA. 2023;
Publication

Rifapentine in Household Contacts of Patients with Leprosy.

Yotsu R, Bedimo R. The New England journal of medicine. 2023; 389 (7) : 672-673.
Publication

Rifapentine in Household Contacts of Patients with Leprosy. Reply.

Wang L, Xiong J, Wang H. The New England journal of medicine. 2023; 389 (7) : 673.
Publication

A Review of Software and Mobile Apps to Support the Clinical Diagnosis of Hansen Disease.

Costa W, de Oliveira A, Aguilar G, et al. JMIR dermatology. 2023;
Download PDF
Publication

Increased anti-M. Leprae PGL-I igm levels in a child who developed leprosy

Lema T, Bobosha K, Kasang C, et al. Ethiopian Medical Journal. 2023; 60 (3) : 293-295.
Download PDF
Publication

Involvement of Medical Colleges in Implementation of National Strategic Plan 2023-27 for Leprosy Elimination: A Roadmap

Kishore J, Paul B, Roy R. Epidemiology International. 2023; 8 (2) : 4-6.
Download PDF
Publication

Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era

Samosir PM, Axelia PG, Alkaff FF, et al. PAGEPress Publications. Dermatology Reports. 2023;
Download PDF
Publication

Analysis of misdiagnosed or delayed-diagnosed Leprosy bacillus infection from 1990 to 2020 with a prophet time series prediction in Hubei Province, China

Chen L, Zheng W, Dong X, et al. Ovid Technologies (Wolters Kluwer Health). Medicine. 2023; 102 (32) : 1-7.
Download PDF
Publication

Deep learning for AI-based diagnosis of skin-related neglected tropical diseases: A pilot study.

Yotsu R, Ding Z, Hamm J, et al. PLoS neglected tropical diseases. 2023; 17 (8) : 1-12.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 182
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD